Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in VERU — Veru Inc.

CIK 1423053 MIAMI, FL
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$193,988
+$95,683 QoQ
Shares Held
61,977
+39.3% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Derivatives in VERU

reported options exposure · as of Jun 30, 2026
CallValue
$186,548
CallShares
59,600
PutValue
$452,285
PutShares
144,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. VERU ranks #320 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in VERU

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $186,548 59,600
2026-06-30 $193,988 61,977
2026-06-30 $452,285 144,500
2026-03-31 $56,576 25,600
2026-03-31 $98,305 44,482
2026-03-31 $26,078 11,800
2025-12-31 $240,881 112,562
2025-12-31 $44,298 20,700
2025-09-30 $166,242 43,748
2025-09-30 $94,544 24,880
2025-09-30 $45,334 11,930
2025-06-30 $190,994 329,300
2025-06-30 $317,682 547,728
2025-06-30 $29,290 50,500
2025-03-31 $34,496 70,400
2025-03-31 $113,765 232,174
2025-03-31 $187,082 381,800
2024-12-31 $128,700 198,000
2024-12-31 $161,720 248,800
2024-12-31 $268,333 412,821
2024-09-30 $200,123 259,900
2024-09-30 $79,079 102,700
2024-06-30 $81 97
2024-06-30 $108,612 129,300
2024-06-30 $104,076 123,900
2024-03-31 $49,210 70,300
2024-03-31 $93,380 133,400
2024-03-31 $5,600 8,000
2023-12-31 $76,608 106,400
2023-12-31 $244,368 339,400
2023-09-30 $137,376 190,800
2023-09-30 $242,856 337,300
2023-06-30 $22,736 19,106
2023-06-30 $547,400 460,000
2023-06-30 $496,587 417,300
2023-03-31 $65,168 56,180
2023-03-31 $774,764 667,900
2023-03-31 $687,764 592,900
2022-12-31 $3,645,702 690,474
2022-12-31 $4,150,080 786,000
2022-12-31 $6,629,568 1,255,600
2022-09-30 $26,853,120 2,331,000
2022-09-30 $8,218,816 713,439
2022-09-30 $16,980,480 1,474,000
2022-06-30 $2,857,770 252,900
2022-06-30 $4,049,920 358,400
2022-06-30 $2,399,283 212,326
2022-03-31 $2,146,553 444,421
2022-03-31 $343,413 71,100
2022-03-31 $213,003 44,100